LCTA-2034

highly potent anthra(2,3-b)furan with antineoplastic properties

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Kaluzhny, Dmitry N: 1 article (11/2017)
2.	Nikitin, Aleksey A: 1 article (11/2017)
3.	Romanenko, Vladimir I: 1 article (11/2017)
4.	Shchekotikhin, Andrey E: 1 article (11/2017)
5.	Tikhomirov, Alexander S: 1 article (11/2017)
6.	Treshalin, Michael I: 1 article (11/2017)
7.	Treshalina, Helen M: 1 article (11/2017)

1.	Anthrax 11/15/2017 - "To improve the water solubility of the anticancer drug candidate LCTA-2034 (A1), we investigated the formation of complexes of this anthrax[2,3-b]furan congener with the solubilizing 2-hydroxypropyl derivative of β-cyclodextrin HP-βCD (Cavitron®). "